Stay updated on Guselkumab in Psoriasis: Clinical Trial
Sign up to get notified when there's something new on the Guselkumab in Psoriasis: Clinical Trial page.
Latest updates to the Guselkumab in Psoriasis: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedPublications section now includes a note that PubMed-derived publications are automatically populated and may not all pertain to the study; the page revision has been updated to v3.3.2.SummaryDifference0.1%
- Check20 days agoChange DetectedRemoval of the government funding/operating status notice at the top of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check34 days agoChange DetectedThe screenshots show only minor formatting adjustments and small copy edits across the page. There are no changes to the core study data such as the title, identifiers, eligibility criteria, outcomes, enrollment, or locations.SummaryDifference0.2%
- Check63 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference1%
- Check70 days agoChange DetectedAdded a new version label (v3.1.0) and removed several safety-focused topics (drug safety, counterfeit drugs, pharmaceutical preparations, substandard drugs), indicating a shift in page scope away from those subjects.SummaryDifference0.2%
- Check85 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.1%
Stay in the know with updates to Guselkumab in Psoriasis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab in Psoriasis: Clinical Trial page.